Enwei Pharmaceutical Co., Ltd. (SHE:301331)

Enwei Pharmaceutical Revenue

Enwei Pharmaceutical had revenue of 175.33M CNY in the quarter ending March 31, 2026, a decrease of -10.77%. This brings the company's revenue in the last twelve months to 879.60M, up 6.60% year-over-year. In the year 2025, Enwei Pharmaceutical had annual revenue of 900.77M with 10.91% growth.

• Revenue (ttm): 879.60M
• Revenue Growth: +6.60%
• P/S Ratio: 2.97
• Revenue / Employee: 586.01K
• Employees: 1,548
• Market Cap: 2.62B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	900.77M	88.64M	10.91%
Dec 31, 2024	812.13M	26.94M	3.43%
Dec 31, 2023	785.19M	93.62M	13.54%
Jan 1, 2023	691.57M	11.88M	1.75%
Jan 1, 2022	679.70M	45.54M	7.18%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 18, 2026

Data Sources Report a data error